3:54 PM
 | 
Feb 24, 2017
 |  BC Extra  |  Company News

Management Tracks

Celgene Corp. (NASDAQ:CELG) said President and COO Jacqualyn Fouse will retire on June 30. Scott Smith will succeed Fouse effective April 1. He is president of global inflammation and immunology. Terrie Curran will be promoted to president of global inflammation and immunology from head of worldwide commercial markets for inflammation and immunology.

Epigenetics company Storm Therapeutics Ltd. (Cambridge, U.K.) named Keith Blundy CEO. He was CEO at Cancer Research Technology Ltd. (London, U.K.).

Anti-infectives company Symbiomix Therapeutics LLC (Newark,...

Read the full 395 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >